← Leaderboards
Joy Wolfram
Mayo Clinic Jacksonville
$1,077,811
Attributed
$2,155,621
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $578.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,155,621 · 2
By mechanism
R01$1,725,246 · 1
R21$430,375 · 1
Top collaborators
- Latonya J Hickson3 shared
- Delisa Fairweather2 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Katelyn Ann Bruno$970,196
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsMediatingInflammationNovel TherapeuticsSuccessPerformanceEnsureFutureInflammatory ResponseMouse ModelSide EffectSourceTherapeutic AgentsCytokineAnimal ModelDisease ModelAnti-Inflammatory AgentsExtracellular VesiclesCellsInflammatoryMacrophageAffectDasatinibAging Population
Grant awards (5)
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$567,364
R01 · FY2025 · AG
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$578,941
R01 · FY2024 · AG
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease$578,941
R01 · FY2023 · AG
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)$195,625
R21 · FY2021 · AI
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)$234,750
R21 · FY2020 · AI